Despite early research dating back to 1996 that reported increased IL-2levels in the cerebrospinal fluid of adolescent PD patients, effective therapiestargeting IL-2 have not yet been developed, unlike the extensive research on IL-2in cancer treatment. Here, IL2 is linked to Parkinson disease.